A non-interventional observational study in adults and children from 5 years of age assessing the safety and tolerability of GRAZAX in case of concomitant specific immunotherapy (SCIT or SLIT)

Trial Profile

A non-interventional observational study in adults and children from 5 years of age assessing the safety and tolerability of GRAZAX in case of concomitant specific immunotherapy (SCIT or SLIT)

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Timothy grass pollen allergen extract (Grastek) (Primary) ; Immunotherapies
  • Indications Grass pollen hypersensitivity
  • Focus Adverse reactions
  • Sponsors ALK-Abello
  • Most Recent Events

    • 20 May 2014 Status changed from recruiting to completed.
    • 10 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top